Biogen Inc. (BIIB)
BIIB price $241.59 -1.51 -0.62%
- Ticker
- BIIB
- Price
- $241.59
- Change
- -1.51 -0.62%
- Market cap
- $35.70B
- P/E
- 42.80
- Forward P/E
- 19.49
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 38
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while…